Omeprazole (Generic) Normon (Omeprazole Sodium)

Omeprazole is a proton pump inhibitor that acts on gastric acid secretion pathways. It is indicated for several acid‑related disorders:

• Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis.
• Peptic ulcer disease: supports ulcer healing and reduces recurrence risk.
• Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors.
• Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates.
• NSAID‑associated ulcer prophylaxis: lowers the risk of ulcer development in patients requiring chronic NSAID therapy.

• Omeprazole sodium irreversibly binds to the H+/K+‑ATPase enzyme (the gastric proton pump) on the secretory surface of parietal cells. By inhibiting this final step of acid production, it markedly reduces both basal and stimulated gastric acidity, allowing mucosal healing and symptom relief in acid‑related disorders.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhoea: usually self‑limiting.
• Constipation: occasional reports.
• Abdominal pain or discomfort: mild.
• Nausea or vomiting: transient.
• Flatulence: occasional.

Serious or Rare Side Effects

• Severe allergic reactions (anaphylaxis, angioedema): require immediate medical attention.
• Clostridioides difficile‑associated colitis: may present with watery diarrhoea.
• Low magnesium levels (hypomagnesemia): can cause muscle cramps or cardiac arrhythmia.
• Bone fractures (hip, wrist, spine): associated with long‑term use.
• Acute interstitial nephritis: renal impairment signs.
• Liver enzyme elevations: monitor hepatic function if persistent.

Omeprazole should be used with consideration of several safety aspects:

• Pregnancy: limited data, use only if clearly needed.
• Breastfeeding: small amounts excreted in milk; weigh benefits against risks.
• Elderly patients: monitor for bone fracture risk with prolonged therapy.
• Renal or hepatic impairment: dose adjustment may be required.
• Concomitant use with drugs that require gastric acidity for absorption: assess necessity.
• Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazole can affect the pharmacokinetics of several medicines.

Major Interactions (Avoid)

• Clopidogrel: reduced antiplatelet effect, consider alternative therapy.
• Atazanavir or other protease inhibitors: markedly decreased absorption.
• Warfarin: potential increase in INR, monitor coagulation parameters.

Moderate Interactions (Monitor Closely)

• Methotrexate: increased serum levels, especially with high‑dose regimens.
• Digoxin: modest rise in serum concentration.
• Phenytoin: decreased plasma concentrations.
• Ketoconazole and other azole antifungals: reduced absorption, may need dose adjustment.